Antagonist interaction with endogenous AT1 receptors in human cell lines

Biochemical Pharmacology

Volumn 64, Issue 8, 2002, Pages 1207-1214

  Verheijen, Ilse ^a   Vanderheyden, Patrick M L ^a   De Backer, Jean Paul ^a   Bottari, Serge ^b   Vauquelin, Georges ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Angiotensin II; Antagonist; Human AT1 receptor; Insurmountable; NCI h295; Vascular smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; CANDESARTAN; INOSITOL PHOSPHATE; IRBESARTAN; LOSARTAN;

ADRENAL CORTEX CELL; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; CELL TYPE; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BINDING, COMPETITIVE; BIPHENYL COMPOUNDS; CELL LINE; CHO CELLS; CRICETINAE; HUMANS; INOSITOL PHOSPHATES; IODINE RADIOISOTOPES; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES; TRANSFECTION;

EID: 0037107508     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01260-1     Document Type: Article

References (18)

1. Timmermans P.B., Benfield P., Chiu A.T., Herblin W.F. Angiotensin II receptors and functional correlates. Am. J. Hypertens. 5:1992;221S-235S.
2. Zhang J.C., Van Meel A., Pfaffendorf M., Van Zwieten P. Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve. J. Pharmacol. Exp. Ther. 269:1993;509-514.
3. Noda M., Shibouta Y., Inada Y., Ojima M., Wada T., Sanada T. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Biochem. Pharmacol. 46(2):1993;311-318.
4. Dickinson K.E., Cohen R.B., Skwish S., Delaney C.L., Serafino R.P., Poss M.A., Gu Z., Ryono D.E., Moreland S., Powell J.R. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Br. J. Pharmacol. 113(1):1994;179-189.
5. Mochizuki S., Sato T., Furuta K., Hase Y., Ohkura Y., Fukai C. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist. J. Cardiovasc. Pharmacol. 25(1):1995;22-29.
6. Morsing P., Adler G., Brandt-Eliasson U., Karp L., Ohlson K., Renberg L., Sjoquist P.O., Abrahamsson T. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension. 33(6):1999;1406-1413.
7. Timmermans P.B. Pharmacological properties of angiotensin II receptor antagonists. Can. J. Cardiol. 15:1999;26F-28F.
8. 1 receptors. Br. J. Pharmacol. 126:1999;1057-1065.
9. 1 receptor antagonists: the role of tight antagonist binding. Eur. J. Pharmacol. 372(2):1999;199-206.
10. 1 antagonism. J. Pharmacol. Exp. Ther. 273(2):1995;753-761.
11. 2 receptors do not interact with guanine nucleotide binding proteins. Eur. J. Pharmacol. 207:1991;157-163.
12. Vanderheyden P.M.L., Fierens F.L.P., De Backer J.P., Vauquelin G. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese Hamster Ovary cells expressing human angiotensin II type 1 receptors. Biochem. Pharmacol. 59:2000;927-935.
13. 1 receptor-transfected Chinese hamster ovary cells Eur. J. Pharmacol. 367(2/3):1999;413-422.
14. 3H ]-irbesartan to human recombinant angiotensin type 1 receptors JRAAS. 1(2):2000;159-169.
15. Verheijen I., Fierens F.L.P., De Backer J.P., Vauquelin G. Interaction between partially insurmountable antagonist valsartan and human recombinant angiotensin type 1 receptors. Fundam. Clin. Pharmacol. 14:2000;577-585.
16. 3H ]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding J. Pharmacol. Exp. Ther. 247(2):1988;710-714.
17. Lagerholm B.C., Thompson N.L. Theory for ligand rebinding at cell membrane surfaces. Biophys. J. 74:1998;1215-1228.
18. l receptor antagonist. Br. J. Pharmacol. 107:1992;1173-1180.